EP3513809
Lyfjasamsetning sem inniheldur tívósaníb
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.9.2017EP published:
2.3.2022EP application number:
17850954.3
EP translation filed:
4.4.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
12.9.2037Expiry date:
12.9.2026Next due date:
30.9.2026
Title in English:
MEDICINAL COMPOSITION COMPRISING TIVOZANIBLanguage of the patent:
English
Timeline
Today
13.9.2017EP application
2.3.2022EP Publication
4.4.2022Translation submitted
15.5.2022Registration published
12.9.2026Expires
Owner
Name:
Kyowa Kirin Co., Ltd.Address:
1-9-2, Otemachi, Chiyoda-ku,, Tokyo, 100-0004, JP
Inventor
Name:
HANIUDA, HirokiAddress:
Tokyo 100-8185, JP
Name:
ENOKIZONO, SachikoAddress:
Tokyo 100-8185, JP
Name:
NAKAZATO, TomoyukiAddress:
Tokyo 100-8185, JP
Name:
TOKUDA, TakuyaAddress:
Tokyo 100-8185, JP
Name:
FUJIKI, NorieAddress:
Tokyo 100-8185, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2016178599Date:
13.9.2016Country:
JP
Classification
Categories:
A61K 45/00, A61K 9/08, A61K 31/4709, A61K 47/02, A61K 47/10, A61K 47/14, A61K 47/26, A61K 47/32, A61K 47/34, A61K 47/38, A61K 47/40, A61P 9/10, A61P 27/02, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 12.9.2022
Expires: 12.9.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 5.9.2023
Expires: 12.9.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.8.2024
Expires: 12.9.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 10.9.2025
Expires: 12.9.2026
Payer: Árnason Faktor ehf.